Noticias de SGMO_US

Noticias del mercado

Últimas noticias sobre SGMO_US — 57 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SGMO_US ✕ 57 resultados
24/04/2026 SGMO_US — GuruFocus
Q3 2025 Sangamo Therapeutics Inc Earnings Call Transcript
23/04/2026 SGMO_US — MarketBeat
Gregory Davis Sells 69,827 Shares of Sangamo Therapeutics (NASDAQ:SGMO) Stock
23/04/2026 SGMO_US — MarketBeat
Sangamo Therapeutics (NASDAQ:SGMO) SVP Sells $89,944.92 in Stock
23/04/2026 SGMO_US — Investing.com
Sangamo Therapeutics SVP sells $89,183 in common stock
23/04/2026 SGMO_US — Investing.com
Sangamo Therapeutics’ head of research & technology sells $17,694 in stock
23/04/2026 SGMO_US — Investing.com ES ← EN
El jefe de investigación y tecnología de Sangamo Therapeutics vende acciones por valor de 17.694 dólares
23/04/2026 SGMO_US — haiphong.gov.vn
Sangamo Therapeutics (SGMO) Stock Fundamentals | Sangamo Therapeutics Inc. misses EPS ests by 79.7% - Stock Trading Network
22/04/2026 SGMO_US — MSN
Sangamo targets summer 2026 for Fabry BLA submission while advancing neurology pipeline and partner talks
22/04/2026 SGMO_US — Xã Thanh Hà ES ← EN
Fundamentos de las acciones de Sangamo Therapeutics (SGMO) | Sangamo Therapeutics Inc. no alcanza las estimaciones de EPS en un 79,7% - Ideas comerciales en tiempo real
22/04/2026 SGMO_US — MSN
Sangamo Therapeutics prices $23M securities offering
19/04/2026 SGMO_US — ACCESS Newswire
SGMO ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Sangamo Therapeutics, Inc. Shareholders Who Lost Money
18/04/2026 SGMO_US — MarketBeat
Sangamo Therapeutics (NASDAQ:SGMO) Lowered to Strong Sell Rating by Zacks Research
07/04/2026 SGMO_US — MarketBeat
HC Wainwright Has Negative Forecast for SGMO FY2026 Earnings
06/04/2026 SGMO_US — news.google.com
Should I Hold Sangamo Therapeutics (SGMO) Stock Now | Price at $0.30, Up 1.13% - Catalyst Driven Stocks
06/04/2026 SGMO_US — news.google.com
Should I Hold Sangamo Therapeutics (SGMO) Stock Now | Price at $0.30, Up 1.13% - Top Trending Breakouts
03/04/2026 SGMO_US — MarketBeat
Equities Analysts Issue Forecasts for SGMO FY2028 Earnings
02/04/2026 SGMO_US — Seeking Alpha
Sangamo Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SGMO) 2026-04-02
02/04/2026 SGMO_US — aktiencheck.de ES ← EN
Sangamo Therapeutics se acerca a un hito clave con la vía acelerada de la FDA para la terapia de la enfermedad de Fabry
31/03/2026 SGMO_US — Yahoo Finance
Sangamo Therapeutics, Inc. Q4 2025 Earnings Call Summary
31/03/2026 SGMO_US — TipRanks
Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty

Página 1 de 3

keyboard_arrow_up